US · Basic Materials · Specialty Chemicals
EPS came in at 1.41 against a street estimate of 1.37 — a beat of 2.9%.
Analysts rate H B Fuller Company a buy (2 buy, 3 hold, 1 sell out of 6) with an average price target of $73.29.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.93% |
| Vanguard Portfolio Management, LLC | 6.97% |
| Dimensional Fund Advisors, Inc. | 5.31% |
| State Street Corp | 5.12% |
| Vanguard Capital Management, LLC | 4.52% |
| Mairs & Power Inc | 4.39% |
| Kayne Anderson Rudnick Investment Management LLC | 3.87% |
| UBS Group AG | 2.68% |
| Document | Date |
|---|---|
| Material agreement · Q3 FY2026 H.B. FULLER COMPANY (FUL) — FORM 8-K SUMMARY July 17, 2026 --- HEADLINE NUMBERS • Term A Loan refinanced: $420,000,000 principal amount with maturi | 2026-07-20 |
| Material agreement · Q3 FY2026 H.B. FULLER COMPANY – FORM 8-K SUMMARY HEADLINE NUMBERS • Acquisition Price: 285 pence in cash per share for Advanced Medical Solutions Group plc (A | 2026-06-26 |
| Quarterly report · Q2 FY2026 H.B. FULLER COMPANY - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net revenue Q2 2026: $950.3 million (up 5.8% vs. Q2 2025: $898.1 million) • Net revenu | 2026-06-25 |
| Results announced · Q3 FY2026 H.B. FULLER COMPANY — Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net revenue: $950 million, up 5.8% year-on-year; organic revenue up 2.6% year-on-y | 2026-06-25 |
| Shareholder vote results · Q2 FY2026 H.B. FULLER COMPANY – 8-K FILING SUMMARY HEADLINE NUMBERS • Annual Meeting of Shareholders held April 16, 2026 • 54,475,433 common shares outstandin | 2026-04-17 |
| Quarterly report · Q1 FY2026 H.B. FULLER COMPANY - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Revenue: $770.8 million (down 2.3% from $788.7 million in Q1 2025) • Net Income: $ | 2026-03-26 |
| Proxy statement · Q2 FY2026 H.B. FULLER COMPANY 2026 PROXY STATEMENT SUMMARY CEO TOTAL COMPENSATION AND CHANGE • CEO Celeste B. Mastin's total compensation for fiscal 2025 is n | 2026-03-04 |
| Annual report FY2025 H.B. FULLER COMPANY - 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Fiscal Year Ended: November 29, 2025 • Shares Outstanding: 54,311,782 sha | 2026-01-22 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.24 / share ex-date Jul 30, 2026 · pay Aug 13, 2026 | 2026-07-30 |
| Dividend | $0.24 / share ex-date Apr 30, 2026 · pay May 14, 2026 | 2026-04-30 |
| Dividend | $0.23 / share ex-date Feb 5, 2026 · pay Feb 19, 2026 | 2026-02-05 |
| Dividend | $0.23 / share ex-date Oct 16, 2025 · pay Oct 30, 2025 | 2025-10-16 |
| Announcement | Date |
|---|---|
| Recommended cash acquisition of Advanced Medical Solutions Group by H.B. Fuller H.B. Fuller Company announced it is acquiring Advanced Medical Solutions Group (AMS) for 285 pence per share in an all-cash deal, valuing the company at approximately £659 million (£715 mill | 2026-06-26 |
| Increases midpoint of full-year adjusted EBITDA and EPS guidance H.B. Fuller, an adhesives and specialty chemicals company, reported strong second quarter 2026 results that exceeded expectations. Key metrics: Net revenue reached $950 million (up 5.8% year | 2026-06-25 |
| Full-year revenue, adjusted EBITDA, and adjusted EPS guidance increased H.B. Fuller, an adhesives and specialty chemicals company, reported Q1 2026 results that demonstrate resilience despite challenging market conditions. Here are the key takeaways: **What Hap | 2026-03-26 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for H B Fuller Company — free to start.
Google PlayApp StoreData updated 2026-09-18.